Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Opioid prescribing practices and medication use following urogynecological surgery.

Solouki S, Plummer M, Agalliu I, Abraham N.

Neurourol Urodyn. 2018 Nov 15. doi: 10.1002/nau.23867. [Epub ahead of print]

PMID:
30431173
2.

Effective Project Management of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate (MADCaP).

Odiaka E, Lounsbury DW, Jalloh M, Adusei B, Diallo TA, Kane PMS, Rockson I, Okyne V, Irusen H, Pentz A, Makinde I, Ajibola OH, Petersen L, McBride J, Petersen DC, Mante S, Agalliu I, Adebiyi AO, Popoola O, Yeboah E, Mensah JE, Hsing A, Fernandez P, Aisuodionoe-Shadrach O, Joffe M, Singh E, Gueye SM, Quintana Y, Fortier B, Rebbeck TR, Andrews C.

J Glob Oncol. 2018 Sep;(4):1-12. doi: 10.1200/JGO.18.00062.

3.

Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.

Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, Pugh E, Romm J, Shelford T, Chinegwundoh F, Adusei B, Mante S, Snyper NY, Agalliu I, Lounsbury DW, Rohan T, Orfanos A, Quintana Y, Jacobson JS, Neugut AI, Gelmann E, Lachance J, Dial C, Diallo TA, Jalloh M, Gueye SM, Kane PMS, Diop H, Ndiaye AJ, Sall AS, Toure-Kane NC, Onyemata E, Abimiku A, Adjei AA, Biritwum R, Gyasi R, Kyei M, Mensah JE, Okine J, Okyne V, Rockson I, Tay E, Tettey Y, Yeboah E, Chen WC, Singh E, Cook MB, Duffy CN, Hsing A, Soo CC, Fernandez P, Irusen H, Aisuodionoe-Shadrach O, Jamda AM, Olabode PO, Nwegbu MM, Ajibola OH, Ajamu OJ, Ambuwa YG, Adebiyi AO, Asuzu M, Ogunbiyi O, Popoola O, Shittu O, Amodu O, Odiaka E, Makinde I, Joffe M, Pentz A, Rebbeck TR.

J Glob Oncol. 2018 Sep;(4):1-14. doi: 10.1200/JGO.18.00063.

4.

Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer.

Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, Burk RD.

Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1168-1175. doi: 10.1158/1055-9965.EPI-18-0287. Epub 2018 Aug 7.

PMID:
30087123
5.

Association of Oral Microbiome With Risk for Incident Head and Neck Squamous Cell Cancer.

Hayes RB, Ahn J, Fan X, Peters BA, Ma Y, Yang L, Agalliu I, Burk RD, Ganly I, Purdue MP, Freedman ND, Gapstur SM, Pei Z.

JAMA Oncol. 2018 Mar 1;4(3):358-365. doi: 10.1001/jamaoncol.2017.4777.

PMID:
29327043
6.

New methods for estimating follow-up rates in cohort studies.

Xue X, Agalliu I, Kim MY, Wang T, Lin J, Ghavamian R, Strickler HD.

BMC Med Res Methodol. 2017 Dec 1;17(1):155. doi: 10.1186/s12874-017-0436-z.

7.

Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer.

Llukani E, Katz BF, Agalliu I, Lightfoot A, Yu SS, Kathrins M, Lee Z, Su YK, Monahan Agnew K, McGill A, Eun DD, Lee DI.

Prostate Int. 2017 Mar;5(1):17-23. doi: 10.1016/j.prnil.2016.12.003. Epub 2017 Jan 12.

8.

Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.

Lengfeld JE, Lutz SE, Smith JR, Diaconu C, Scott C, Kofman SB, Choi C, Walsh CM, Raine CS, Agalliu I, Agalliu D.

Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):E1168-E1177. doi: 10.1073/pnas.1609905114. Epub 2017 Jan 30.

9.

β- and γ-Human Papillomavirus Types and Smoking in Head and Neck Cancer-Reply.

Agalliu I, Wang T, Burk RD.

JAMA Oncol. 2016 May 1;2(5):687-8. doi: 10.1001/jamaoncol.2016.0973. No abstract available.

PMID:
27244681
10.

Improving outcomes in cancer diagnosis, prevention and control: barriers, facilitators and the need for health literacy in Ibadan Nigeria.

Adedimeji AA, Lounsbury D, Popoola O, Asuzu C, Lawal A, Oladoyin V, Crifase C, Agalliu I, Shankar V, Adebiyi A.

Psychooncology. 2017 Oct;26(10):1455-1462. doi: 10.1002/pon.4158. Epub 2016 May 24.

PMID:
27218238
11.

Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.

Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP.

Urolithiasis. 2016 Oct;44(5):399-407. doi: 10.1007/s00240-016-0882-9. Epub 2016 Apr 26.

PMID:
27115405
12.
13.

Associations of Oral α-, β-, and γ-Human Papillomavirus Types With Risk of Incident Head and Neck Cancer.

Agalliu I, Gapstur S, Chen Z, Wang T, Anderson RL, Teras L, Kreimer AR, Hayes RB, Freedman ND, Burk RD.

JAMA Oncol. 2016 Jan 21. doi: 10.1001/jamaoncol.2015.5504. [Epub ahead of print]

14.

A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer.

Palma A, Lounsbury DW, Schlecht NF, Agalliu I.

Am J Epidemiol. 2016 Feb 1;183(3):227-36. doi: 10.1093/aje/kwv262. Epub 2015 Dec 24. Erratum in: Am J Epidemiol. 2016 Mar 15;183(6):597.

15.

3% Hypertonic Saline Versus Normal Saline in Inpatient Bronchiolitis: A Randomized Controlled Trial.

Silver AH, Esteban-Cruciani N, Azzarone G, Douglas LC, Lee DS, Liewehr S, Nazif JM, Agalliu I, Villegas S, Rhim HJ, Rinke ML, O'Connor K.

Pediatrics. 2015 Dec;136(6):1036-43. doi: 10.1542/peds.2015-1037. Epub 2015 Nov 9.

16.

The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria.

Agalliu I, Adebiyi AO, Lounsbury DW, Popoola O, Jinadu K, Amodu O, Paul S, Adedimeji A, Asuzu C, Asuzu M, Ogunbiyi OJ, Rohan T, Shittu OB.

BMC Public Health. 2015 Apr 26;15:425. doi: 10.1186/s12889-015-1754-x.

17.

The visceral fat compartment is independently associated with changes in urine constituent excretion in a stone forming population.

Fram EB, Agalliu I, DiVito J, Hoenig DM, Stern JM.

Urolithiasis. 2015 Jun;43(3):213-20. doi: 10.1007/s00240-015-0770-8. Epub 2015 Apr 23.

PMID:
25903669
18.

Construct validation of the dietary inflammatory index among postmenopausal women.

Tabung FK, Steck SE, Zhang J, Ma Y, Liese AD, Agalliu I, Hingle M, Hou L, Hurley TG, Jiao L, Martin LW, Millen AE, Park HL, Rosal MC, Shikany JM, Shivappa N, Ockene JK, Hebert JR.

Ann Epidemiol. 2015 Jun;25(6):398-405. doi: 10.1016/j.annepidem.2015.03.009. Epub 2015 Mar 19.

19.

The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics.

Agalliu I, Williams S, Adler B, Androga L, Siev M, Lin J, Xue X, Huang G, Strickler HD, Ghavamian R.

Cancer Causes Control. 2015 Jun;26(6):821-30. doi: 10.1007/s10552-015-0554-z. Epub 2015 Mar 14.

20.

Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS.

Cancer. 2015 Apr 15;121(8):1265-72. doi: 10.1002/cncr.29075. Epub 2015 Mar 9.

21.

Outcomes and Management Considerations in Patients on Dialysis Undergoing Laparoscopic Radical Nephrectomy for Renal-Cell Carcinoma.

Keehn A, Maiman R, Agalliu I, Taylor J, Ghavamian R.

J Endourol. 2015 Jun;29(6):691-5. doi: 10.1089/end.2014.0484. Epub 2015 Feb 5.

PMID:
25423552
22.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.

23.

Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25.

Fejerman L, Ahmadiyeh N, Hu D, Huntsman S, Beckman KB, Caswell JL, Tsung K, John EM, Torres-Mejia G, Carvajal-Carmona L, Echeverry MM, Tuazon AM, Ramirez C; COLUMBUS Consortium, Gignoux CR, Eng C, Gonzalez-Burchard E, Henderson B, Le Marchand L, Kooperberg C, Hou L, Agalliu I, Kraft P, Lindström S, Perez-Stable EJ, Haiman CA, Ziv E.

Nat Commun. 2014 Oct 20;5:5260. doi: 10.1038/ncomms6260.

24.

Effect of visceral obesity on minimally invasive partial nephrectomy.

Ioffe E, Hakimi AA, Oh SK, Agalliu I, Ginzburg N, Williams SK, Kao L, Rozenblit AM, Ghavamian R.

Urology. 2013 Sep;82(3):612-8. doi: 10.1016/j.urology.2013.04.058.

PMID:
23987153
25.

Prospective analysis of association between statin use and breast cancer risk in the women's health initiative.

Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, Lane D, Luo J, Park HL, Thomas F, Wactawski-Wende J, Simon MS.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1868-76. doi: 10.1158/1055-9965.EPI-13-0562. Epub 2013 Aug 23.

26.

Effects of visceral fat area and other metabolic parameters on stone composition in patients undergoing percutaneous nephrolithotomy.

Zhou T, Watts K, Agalliu I, DiVito J, Hoenig DM.

J Urol. 2013 Oct;190(4):1416-20. doi: 10.1016/j.juro.2013.05.016. Epub 2013 May 14.

PMID:
23685097
27.

Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.

Schooling CM, Sembajwe G, Agalliu I.

Eur Urol. 2013 Sep;64(3):e59-60. doi: 10.1016/j.eururo.2013.04.017. Epub 2013 Apr 19. No abstract available.

PMID:
23623050
28.

Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction.

Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L.

PLoS One. 2013;8(4):e60083. doi: 10.1371/journal.pone.0060083. Epub 2013 Apr 3.

29.

Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4.

Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, Kooperberg C, LaCroix A, Li D, Mandelson MT, Olson SH, Petersen G, Risch HA, Yu K, Wolpin BM, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovanucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman-Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Tjønneland A, Trichopoulos D, Virtamo J, Visvanathan K, Elena JW, Yu H, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ.

Cancer Causes Control. 2013 Mar;24(3):595-602. doi: 10.1007/s10552-012-0138-0. Epub 2013 Jan 19.

30.

Detectability and reproducibility of plasma levels of chemokines and soluble receptors.

Agalliu I, Xue X, Cushman M, Cornell E, Hsing AW, Kaplan RC, Anastos K, Rajpathak S, Ho GY.

Results Immunol. 2013 Aug 5;3:79-84. doi: 10.1016/j.rinim.2013.07.001. eCollection 2013.

31.

Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: our experience and meta-analysis.

Mass AY, Agalliu I, Laze J, Lepor H.

J Urol. 2012 Sep;188(3):786-91. doi: 10.1016/j.juro.2012.05.011. Epub 2012 Jul 19.

PMID:
22818136
32.

Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer.

Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, Hartge P, Hoover RN, Holly EA, Jacobs EJ, Klein AP, LaCroix A, Mandelson MT, Petersen G, Zheng W, Agalliu I, Albanes D, Boutron-Ruault MC, Bracci PM, Buring JE, Canzian F, Chang K, Chanock SJ, Cotterchio M, Gaziano JM, Giovannucci EL, Goggins M, Hallmans G, Hankinson SE, Hoffman Bolton JA, Hunter DJ, Hutchinson A, Jacobs KB, Jenab M, Khaw KT, Kraft P, Krogh V, Kurtz RC, McWilliams RR, Mendelsohn JB, Patel AV, Rabe KG, Riboli E, Shu XO, Tjønneland A, Tobias GS, Trichopoulos D, Virtamo J, Visvanathan K, Watters J, Yu H, Zeleniuch-Jacquotte A, Amundadottir L, Stolzenberg-Solomon RZ.

Carcinogenesis. 2012 Jul;33(7):1384-90. doi: 10.1093/carcin/bgs151. Epub 2012 Apr 20.

33.

Comparison of health-related quality-of-life outcomes for African-American and Caucasian-American men after radical prostatectomy.

Lee EW, Marien T, Laze J, Agalliu I, Lepor H.

BJU Int. 2012 Oct;110(8):1129-33. doi: 10.1111/j.1464-410X.2012.10951.x. Epub 2012 Mar 19.

34.

Analysis of robotic-assisted laparoscopic pyleloplasty for primary versus secondary repair in 119 consecutive cases.

Niver BE, Agalliu I, Bareket R, Mufarrij P, Shah O, Stifelman MD.

Urology. 2012 Mar;79(3):689-94. doi: 10.1016/j.urology.2011.10.072.

PMID:
22386423
35.

Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy.

Hakimi AA, Agalliu I, Ho GY, Ghavamian R, Yu C, Kattan MW, Rabbani F.

J Urol. 2012 Apr;187(4):1234-40. doi: 10.1016/j.juro.2011.11.090. Epub 2012 Feb 14.

PMID:
22335862
36.

Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry.

Wang Z, Parikh H, Jia J, Myers T, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Ghosh A, Thun MJ, Gapstur SM, Ryan Diver W, Virtamo J, Albanes D, Cancel-Tassin G, Valeri A, Cussenot O, Offit K, Giovannucci E, Ma J, Stampfer MJ, Michael Gaziano J, Hunter DJ, Dutra-Clarke A, Kirchhoff T, Alavanja M, Freeman LB, Koutros S, Hoover R, Berndt SI, Hayes RB, Agalliu I, Burk RD, Wacholder S, Thomas G, Amundadottir L.

Hum Genet. 2012 Jul;131(7):1173-85. doi: 10.1007/s00439-012-1139-5. Epub 2012 Jan 24.

37.

Blood loss during radical prostatectomy: impact on clinical, oncological and functional outcomes and complication rates.

Djavan B, Agalliu I, Laze J, Sadri H, Kazzazi A, Lepor H.

BJU Int. 2012 Jul;110(1):69-75. doi: 10.1111/j.1464-410X.2011.10812.x. Epub 2011 Dec 7.

38.

Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai.

Agalliu I, Costello S, Applebaum KM, Ray RM, Astrakianakis G, Gao DL, Thomas DB, Checkoway H, Eisen EA.

Cancer Causes Control. 2011 Oct;22(10):1397-404. doi: 10.1007/s10552-011-9812-x. Epub 2011 Jul 6.

39.

Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent.

Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Stanford JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B, Ragin C.

Carcinogenesis. 2011 Sep;32(9):1361-5. doi: 10.1093/carcin/bgr119. Epub 2011 Jun 24.

40.

Preoperative and intraoperative measurements of urethral length as predictors of continence after robot-assisted radical prostatectomy.

Hakimi AA, Faleck DM, Agalliu I, Rozenblit AM, Chernyak V, Ghavamian R.

J Endourol. 2011 Jun;25(6):1025-30. doi: 10.1089/end.2010.0692. Epub 2011 May 13.

PMID:
21568755
41.

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

BJU Int. 2011 Nov;108(10):1582-7. doi: 10.1111/j.1464-410X.2011.10173.x. Epub 2011 Mar 28.

42.

Oxidative balance score and risk of prostate cancer: results from a case-cohort study.

Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE.

Cancer Epidemiol. 2011 Aug;35(4):353-61. doi: 10.1016/j.canep.2010.11.002. Epub 2010 Dec 9.

PMID:
21145797
43.

Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population.

Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, Bailey-Wilson JE, Burk RD.

Prostate. 2010 Nov 1;70(15):1716-27. doi: 10.1002/pros.21207.

44.

Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, Amundadottir L, Boutron-Ruault MC, Buring JE, Canzian F, Clipp S, Dorronsoro M, Gaziano JM, Giovannucci EL, Hankinson SE, Hartge P, Hoover RN, Hunter DJ, Jacobs KB, Jenab M, Kraft P, Kooperberg C, Lynch SM, Sund M, Mendelsohn JB, Mouw T, Newton CC, Overvad K, Palli D, Peeters PH, Rajkovic A, Shu XO, Thomas G, Tobias GS, Trichopoulos D, Virtamo J, Wactawski-Wende J, Wolpin BM, Yu K, Zeleniuch-Jacquotte A.

Int J Cancer. 2010 Sep 1;127(6):1421-8. doi: 10.1002/ijc.25148.

45.

Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study.

Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL.

Cancer Causes Control. 2010 Feb;21(2):289-300. doi: 10.1007/s10552-009-9461-5. Epub 2009 Nov 10.

46.

Illumina DNA test panel-based genotyping of whole genome amplified-DNA extracted from hair samples: performance and agreement with genotyping results from genomic DNA from buccal cells.

Agalliu I, Schweitzer PA, Leanza SM, Burk RD, Rohan TE.

Clin Chem Lab Med. 2009;47(5):516-22. doi: 10.1515/CCLM.2009.106.

PMID:
19397482
47.

Motor neurons with axial muscle projections specified by Wnt4/5 signaling.

Agalliu D, Takada S, Agalliu I, McMahon AP, Jessell TM.

Neuron. 2009 Mar 12;61(5):708-20. doi: 10.1016/j.neuron.2008.12.026.

48.

Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations.

Agalliu I, Gern R, Leanza S, Burk RD.

Clin Cancer Res. 2009 Feb 1;15(3):1112-20. doi: 10.1158/1078-0432.CCR-08-1822.

49.

Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.

FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG.

BMC Cancer. 2008 Aug 11;8:230. doi: 10.1186/1471-2407-8-230.

50.

Statin use and risk of prostate cancer: results from a population-based epidemiologic study.

Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL.

Am J Epidemiol. 2008 Aug 1;168(3):250-60. doi: 10.1093/aje/kwn141. Epub 2008 Jun 12.

Supplemental Content

Loading ...
Support Center